Kingworld Medicines Group Ltd.(HK:1110)
HK$0.38+0.01 (+1.35%)
HK:1110
Kingworld Medicines Group Ltd. financials statements
HK$0.38
At close:+0.01 (+1.35%)
Want to see HK:1110 full AI Analyst Report?
Kingworld Medicines Group Ltd. (1110) Financial Statements
0 Followers
Kingworld Medicines Group Ltd. Financial Overview
Kingworld Medicines Group Ltd.'s market cap is currently ¥227.44M. The company's EPS TTM is ¥0.02; its P/E ratio is 16.86; and it has a dividend yield of 8.45%. Kingworld Medicines Group Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 917.34M | ¥ 1.06B | ¥ 1.08B | ¥ 957.70M | ¥ 847.39M |
| Gross Profit | ¥ 247.91M | ¥ 270.45M | ¥ 280.67M | ¥ 277.63M | ¥ 263.60M |
| Operating Income | ¥ 63.16M | ¥ 89.70M | ¥ 96.81M | ¥ 72.23M | ¥ 72.22M |
| EBITDA | ¥ 82.70M | ¥ 110.77M | ¥ 125.48M | ¥ 118.07M | ¥ 116.00M |
| Net Income | ¥ 11.28M | ¥ 41.56M | ¥ 38.10M | ¥ 22.74M | ¥ 30.32M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 274.70M | ¥ 249.60M | ¥ 194.03M | ¥ 256.17M | ¥ 198.41M |
| Total Assets | ¥ 1.44B | ¥ 1.42B | ¥ 1.34B | ¥ 1.26B | ¥ 1.21B |
| Total Debt | ¥ 434.05M | ¥ 402.44M | ¥ 354.43M | ¥ 290.68M | ¥ 238.96M |
| Net Debt | ¥ 169.53M | ¥ 167.14M | ¥ 180.75M | ¥ 48.52M | ¥ 51.03M |
| Total Liabilities | ¥ 753.86M | ¥ 710.04M | ¥ 638.30M | ¥ 569.15M | ¥ 493.19M |
| Stockholders' Equity | ¥ 617.97M | ¥ 639.79M | ¥ 619.03M | ¥ 615.58M | ¥ 616.90M |
| Cash Flow | |||||
| Free Cash Flow | ¥ 54.92M | ¥ 94.73M | ¥ -63.25M | ¥ 93.64M | ¥ 22.88M |
| Operating Cash Flow | ¥ 84.56M | ¥ 135.82M | ¥ 42.28M | ¥ 186.55M | ¥ 81.20M |
| Investing Cash Flow | ¥ -20.11M | ¥ -27.64M | ¥ -120.63M | ¥ -84.05M | ¥ -50.84M |
| Financing Cash Flow | ¥ -30.82M | ¥ -47.61M | ¥ 4.37M | ¥ -51.31M | ¥ -87.20M |
Currency in CNY
